World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
29482
World Ranking
9786
National Ranking
5030

Overview

Nai-Kong V. Cheung is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research is primarily concentrated in the field of Medicine, with substantial work in Oncology, Neurology, Radiology, Nuclear Medicine and Imaging, Immunology, and Molecular Biology. The scope of their studies includes significant focus on Neuroblastoma Research and Treatments, CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Radiopharmaceutical Chemistry and Applications, Cancer, Hypoxia, and Metabolism, Lung Cancer Research Studies, and Immunotherapy and Immune Responses.

Cheung's recent publications span several high-impact venues. Notable recent papers include:

  • Cancer immunotherapy via targeted TGF-β signalling blockade in TH cells, 2020, Nature
  • Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations, 2020, Nature Communications
  • Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors, 2021, Nature Cancer
  • Targets and Antibody Formats for Immunotherapy of Neuroblastoma, 2020, Journal of Clinical Oncology
  • Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression, 2020, Journal of Clinical Oncology

The scientist frequently collaborates with several researchers, including:

  • Hong-Fen Guo
  • Shakeel Modak
  • Brian H. Kushner
  • Steven M. Larson
  • Ellen M. Basu

Cheung has published extensively across multiple scientific journals. Their most frequent publication venues are:

  • Journal of Clinical Oncology
  • Journal for ImmunoTherapy of Cancer
  • Journal of Hematology & Oncology
  • Cancer Research
  • Journal of Nuclear Medicine

In addition to primary fields, Cheung's work spans important subfields such as Oncology, Neurology, Radiology, Nuclear Medicine and Imaging, Immunology, and Molecular Biology.

Their research topics center on:

  • Neuroblastoma Research and Treatments
  • CAR-T cell therapy research
  • Monoclonal and Polyclonal Antibodies Research
  • Radiopharmaceutical Chemistry and Applications
  • Cancer, Hypoxia, and Metabolism
  • Lung Cancer Research Studies
  • Immunotherapy and Immune Responses

Best Publications

  • Neuroblastoma: developmental biology, cancer genomics and immunotherapy

    Nai-Kong V. Cheung;Michael A. Dyer;Michael A. Dyer;Michael A. Dyer

  • Radioimmunotherapy of human tumours

    Steven M. Larson;Jorge A. Carrasquillo;Nai Kong V Cheung;Oliver W. Press

  • Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma

    Nai-Kong V. Cheung;Jinghui Zhang;Charles Lu;Matthew Parker

  • Malignant pheochromocytoma: Current status and initiatives for future progress

    Graeme Eisenhofer;Stefan R. Bornstein;Frederieke M. Brouwers;Nai Kong V. Cheung

  • Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.

    N. K V Cheung;Hillard M Lazarus;F. D. Miraldi;C. R. Abramowsky

  • Association of CYP3A4 genotype with treatment-related leukemia

    Carolyn A. Felix;Amy H. Walker;Beverly J. Lange;Terence M. Williams

  • Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy.

    B. H. Kushner;M. P. Laquaglia;N. Wollner;P. A. Meyers

  • Monoclonal Antibodies to a Glycolipid Antigen on Human Neuroblastoma Cells

    Nai Kong V. Cheung;Ulla M. Saarinen;John E. Neely;Bonnie Landmeier

  • ANTIGEN-DEPENDENT CD28 SIGNALING SELECTIVELY ENHANCES SURVIVAL AND PROLIFERATION IN GENETICALLY MODIFIED ACTIVATED HUMAN PRIMARY T LYMPHOCYTES

    Anja Krause;Hong-Fen Guo;Jean-Baptiste Latouche;Cuiwen Tan

  • Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura

    James B. Bussel;Robert P. Kimberly;Robert D. Inman;Irving Schulman

  • The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma.

    Teeara Berry;William Luther;Namrata Bhatnagar;Yann Jamin

  • MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors.

    Hong Xu;Irene Y. Cheung;Hong-Fen Guo;Nai-Kong V. Cheung

  • Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission.

    Nai-Kong V. Cheung;Irene Y. Cheung;Brian H. Kushner;Irina Ostrovnaya

  • Characteristics of Stem Cells from Human Neuroblastoma Cell Lines and in Tumors

    Jeanette D Walton;David R Kattan;Sharon K Thomas;Barbara A Spengler

  • Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma.

    Kim Kramer;Brian H. Kushner;Shakeel Modak;Neeta Pandit-Taskar

  • Orally administered β-glucans enhance anti-tumor effects of monoclonal antibodies

    Nai-Kong V. Cheung;Shakeel Modak;Andrew Vickers;Benny Knuckles

  • Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment

    Nidale Tarek;Jean Benoit Le Luduec;Meighan M. Gallagher;Junting Zheng

  • Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age.

    N.-K. V. Cheung;B. H. Kushner;I. Y. Cheung;K. Kramer

  • GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma.

    Brian H. Kushner;Nai-Kong V. Cheung

  • Phase II Trial of the Anti-GD2 Monoclonal Antibody 3F8 and Granulocyte-Macrophage Colony-Stimulating Factor for Neuroblastoma

    Brian H. Kushner;Kim Kramer;Nai-Kong V. Cheung

Frequent Co-Authors

Steven M. Larson
Steven M. Larson Memorial Sloan Kettering Cancer Center
William L. Gerald
William L. Gerald Memorial Sloan Kettering Cancer Center
Michael P. LaQuaglia
Michael P. LaQuaglia Memorial Sloan Kettering Cancer Center
Suzanne L. Wolden
Suzanne L. Wolden Memorial Sloan Kettering Cancer Center
Glenn Heller
Glenn Heller Memorial Sloan Kettering Cancer Center
John L. Humm
John L. Humm Memorial Sloan Kettering Cancer Center
Jason S. Lewis
Jason S. Lewis Memorial Sloan Kettering Cancer Center
Jorge A. Carrasquillo
Jorge A. Carrasquillo Memorial Sloan Kettering Cancer Center
Katharine C. Hsu
Katharine C. Hsu Memorial Sloan Kettering Cancer Center
Richard J. O'Reilly
Richard J. O'Reilly Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare but considering alternative pathways or flexible learning options, several online nursing programs are available. Many students seek online rn to bsn programs without clinicals for their convenience and streamlined curriculum. These programs allow registered nurses to advance their qualifications without the need for additional on-site clinical hours.

If you aim to reach the highest levels in nursing, advanced degrees can be pursued through distance learning. There are reputable dnp online programs designed to fast-track your Doctor of Nursing Practice degree, helping you enter leadership roles more quickly. Some also prefer enrolling in dnp online programs that focus on accessibility and flexibility, catering to working professionals.

Alternatively, those seeking to begin their nursing careers rapidly may consider a lpn fast track program. These accelerated options can provide a quicker entry into the workforce and offer a stepping stone toward advanced medical or nursing degrees.

Best Scientists Citing Nai-Kong V. Cheung

Trending Scientists

Recently Published Articles